2-环己基氨基乙醇,CAS 登记号 2842-38-8,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于有机化学品。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。
有机化学品
每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。
本页已列出 2-环己基氨基乙醇 的 CAS 号:2842-38-8,可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。
2-cyclohexylaminoethanol · CAS 2842-38-8 · C8H17NO. UNII F723W4Z785.
| CAS Registry Number | 2842-38-8 |
|---|---|
| PubChem CID | 17827 |
| Molecular formula | C8H17NO |
| IUPAC name | 2-(cyclohexylamino)ethanol |
| UNII (FDA) | F723W4Z785 |
| Molecular Weight | 143.23 |
|---|---|
| XLogP3 | 0.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 3 |
| Exact Mass | 143.131014166 |
| Monoisotopic Mass | 143.131014166 |
| Topological Polar Surface Area | 32.3 |
| Heavy Atom Count | 10 |
| Formal Charge | 0 |
| Reported hazard statements | H302 (88.9%), H315 (100%), H318 (88.9%), H319 (11.1%), H335 (97.8%) |
|---|
H302 (88.9%): Harmful if swallowed [Warning Acute toxicity, oral]
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
2842-38-8; 2-(CYCLOHEXYLAMINO)ETHANOL; Ethanol, 2-(cyclohexylamino)-; Abbomeen E-25 aerosol; Abromeen E-25; N-(2-Hydroxyethyl)cyclohexylamine; 2-Cyclohexylaminoethanol; Cyclohexlaminoethanol; Cyclohexylamine, hydroxyethyl-; N-Hydroxyethylcyclohexylamine; N-(2-Hydroxyethyl) cyclohexylamine; NSC 1505; BRN 1071413; N-(Cyclohexylamino)ethanol (VAN); Ethanol, 2-(cyclohexylamino)-, (aerosol); EINECS 220-636-4
CAS 2842-38-8; molecular formula C8H17NO; molecular weight — g/mol.
2842-38-8, 2-(CYCLOHEXYLAMINO)ETHANOL, Ethanol, 2-(cyclohexylamino)-, Abbomeen E-25 aerosol, Abromeen E-25, N-(2-Hydroxyethyl)cyclohexylamine.
Hazard statements reported: H302, H315, H318, H319, H335.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.